Childhood Cardiomyopathies
A Study in Tertiary Care Hospital in Upper Egypt
Keywords:
Childhood cardiomyopathy, Dilated cardiomyopathy, Hypertrophic Cardiomyopathy, EgyptAbstract
Introduction: Cardiomyopathy (CMP) is defined by the World Health Organization (WHO) as a disease of the myocardium associated with cardiac dysfunction. An understanding of CMP is very important, as it is a common cause of heart failure in children, and the most common indication for heart transplantation in children older than one year, but data on CMP in Egypt are scarce. The aim of this study was to determine the number, risk factors, clinical presentation, complications and outcome of different types of childhood cardiomyopathies in Sohag University Hospital.
Methods: This cross-sectional hospital based study enrolled fifty children with Cardiomyopathy in Pediatric Departments, Neonatal Care Units, and Cardiac Outpatient Clinics in Sohag University Hospital from March 01, 2014 to February 28, 2015.
Results: Cases with Dilated Cardiomyopathy (DCMP) were 38 (76%), and those who had Hypertrophic Cardiomyopathy (HCMP) were 12 (24%). Dyspnea was the most common presenting complaint in 71% of cases. In cases with DCMP, the mean EF was 33.8, and FS was 17.11, while in cases with HCMP, the mean EF was 70.75, FS was 37. Fifty percent of cases were found to have moderate to severe PHT. Serum CK-MB was elevated in 3 (6%) cases, while serum Troponin I was elevated in 2 (4.2%) cases who diagnosed as having myocarditis. Viral myocarditis was the most common identified etiological agent responsible for 14 (37%) cases with DCMP.
Conclusions: CMP represents a considerable percentage of children with cardiac disorders. DCMP is the most common type, usually presented with congestive heart failure, and the most common cause is myocarditis. L-Carnitine profile was normal in all cases, despite its routine use. Pediatricians need to raise their clinical suspicion to CMPs, as atypical presentations are not uncommon. To do screening for other family members, cardiac enzymes (CK-MB, Troponin I) have to be done in all newly diagnosed CMP cases, along with a revision of the routine prescription of L-Carnitine.
References
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995
World Health Organization/ International Society and Federation of Cardiology Task Force on the
definition and classification of cardiomyopathies. Circulation. 1996; 93(5): 841-2. doi:
1161/01.CIR.93.5.841. PMID: 8598070.
Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, et al. The pediatric cardiomyopathy
registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010; 6(4): 401-13. doi:
1016/j.hfc.2010.05.002. PMID: 20869642, PMCID: PMC2946942.
Hong YM. Cardiomyopathies in children. Korean J Pediatr. 2013; 56(2): 52-9. doi:
3345/kjp.2013.56.2.52. PMID: 23482511, PMCID: PMC3589591.
Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, et al. The incidence of pediatric
cardiomyopathy in two regions of the United States. N Engl J Med. 2003; 348(17): 1647-55. doi:
1056/NEJMoa021715. PMID: 12711739.
Elmasry OA, Kamel TB, El-Feki NF. Pediatric cardiomyopathies over the last decade: a retrospective
observational epidemiology study in Ain Shams University, Children's Hospital (Cairo, Egypt). J Egypt
Public Health Assoc. 2011; 86(3-4): 63-7. doi: 10.1097/01.EPX.0000399140.68151.6a. PMID: 21844761.
Towbin JA, Bowles NE. The failing heart. Nature. 2002; 415(6868): 227-33. doi: 10.1038/415227a. PMID:
Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010; 375(9716): 752-62. doi: 10.1016/S0140- 6736(09)62023-7. PMID: 20189027.
Moak JP, Kaski JP. Hypertrophic cardiomyopathy in children. Heart. 2012; 98(14): 1044-54. doi:
1136/heartjnl-2011-300531. PMID: 22591735.
Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287(10): 1308-20. doi:
1001/jama.287.10.1308. PMID: 11886323.
Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial
biopsy in the management of cardiovascular disease: a scientific statement from the American Heart
Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by
the Heart Failure Society of America and the Heart Failure Association of the European Society of
Cardiology. J Am Coll Cardiol. 2007; 50(19): 1914-31. doi: 10.1016/j.jacc.2007.09.008. PMID: 17980265.
Semsarian C. Cardiac Genetics Diseases Council Writing Group. Guidelines for the diagnosis and
management of hypertrophic cardiomyopathy. Heart Lung Circ. 2011; 20: 688-90. doi:
1016/j.hlc.2011.07.017. PMID: 22000299.
Oh JH, Hong YM, Choi JY, Kim SJ, Jung JW, Sohn S, et al. Idiopathic cardiomyopathies in Korean
children. 9-Year Korean Multicenter Study. Circ J. 2011; 75(9): 2228-34. doi: 10.1253/circj.CJ-11-0051.
PMID: 21747192.
Saadallah AA, Rashed MS. Newborn screening: experiences in the Middle East and North Africa. J Inherit
Metab Dis. 2007; 30(4): 482-9. doi: 10.1007/s10545-007-0660-5. PMID: 17701444.
Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes, and outcomes of
dilated cardiomyopathy in children. JAMA. 2006; 296(15): 1867-76. doi: 10.1001/jama.296.15.1867.
PMID: 17047217.
Huang M, Zhang X, Chen S, Sun Y, Xiao Y, Sun J, et al. The effect of carvedilol treatment on chronic
heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
Pediatr Cardiol. 2013; 34(3): 680-5. doi: 10.1007/s00246-012-0527-x. PMID: 23108482.
Saucedo NA, Alarcón AV, Islas GE, De La Cruz LR. Evaluation of the effect of carvedilol in children with
dilated cardiomyopathy. Arch Cardiol Mex. 2008; 78(1): 52-9. PMID: 18581713.
Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, et al. Treating children with
idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol. 2009;
(2): 281-6. doi: 10.1016/j.amjcard.2009.03.033. PMID: 19576361, PMCID: PMC2746101.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
